Cogent

-  Data presented at ASCO annual meeting demonstrate 55% Disease Control Rate (DCR) in heavily pre-treated GIST patients, including 100% DCR and 17% overall response rate (ORR) in efficacy evaluable 2nd-line GIST patients; data immature to…

-   89% ORR in TKI-therapy naïve patients; 73% ORR in all evaluable patients with 27-week median follow-up -   Rapid and deep responses seen including first confirmed CR at 20 weeks; 77% of patients with at least 2 cycles of treatment had…

© Reuters. FILE PHOTO: A T-Mobile logo is advertised on a building sign in Los Angeles, California, U.S., May 11, 2017. REUTERS/Mike Blake By Yuvraj Malik (Reuters) - T-Mobile US (NASDAQ:) Inc is doubling down on 5G services after it…

CAMBRIDGE, Mass. and BOULDER, Colo., June 16, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the…

Cogent Communications -- an internet service provider carrying about 25% of the internet traffic across the globe -- said on Friday it is terminating its service…

New Delhi: Cogent E-Services Ltd has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO). The initial share-sale comprises fresh issue of equity shares aggregating up to Rs…